Antibodies against Jagged1 targeted both tumor- and stroma-expressed Jagged1, blocked Notch/Jagged signalization between smooth muscular and endothelial cells, affected CSC, and effectively reduced metastatic brain lesions in in vitro and in vivo models of breast cancer. This evidence concerns the gene JAG1 and breast carcinoma.